Immunocompromised Patients Could Get Help from New Vaccine Strategy

Bolstering the immune system is not a new strategy when trying to protect against deadly pathogens, yet for those individuals that are immunocompromised, this...

Lilly, Dicerna Launch $3.7B+ RNAi Collaboration

Eli Lilly will apply Dicerna Pharmaceuticals’ GalXC™ RNA interference (RNAi) technology platform to discover, develop, and commercialize new treatments based on more than 10...

AbbVie Takes Control of Cystic Fibrosis Collaboration with Galapagos

AbbVie will assume full development and commercialization responsibilities for all cystic fibrosis (CF) programs partnered with Galapagos, under a restructuring of the companies’ five-year-old...

Anti-Obesity “Biochemical Cigarette” Exploits Body’s Responses to Cold and Smoking

Researchers in Europe and Australia have developed an anti-obesity “chemical cigarette” that exploits the body’s natural responses to both cold exposure and smoking. The...

Breast Cancer Immunotherapy Delivered without Side Effects

While cancer immunotherapy is one of the most exciting new research areas due to the potential it holds for treating tumors that have been...

Lavender Scent Reduces Anxiety through Smell Receptors

Traditional medicine has long used aromatic plant-derived compounds such as lavender extract as treatments for anxiety, but how these compounds might work at the...

Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes

A large Phase III trial, the Impassion130 trial, has produced results supporting the use of chemotherapy plus immunotherapy as first-line treatment in certain patients...

Recently Featured

Stay Connected

555,298FansLike
49,866FollowersFollow
Scroll Up